Quercetin cu activitate: antioxidanta, anti-inflammatorie,
antivrala, immunomodulatoare, anticancer, gastroprotectiva, anti-alergica
si in prevenirea
de complicatii ale diabetului.
3. Quercetina un bioflavonoid produs natural cu potenta
inalta farmacologica: reviu
biologic
Quercetina un bioflavonoid produs natural cu potenta inalta farmacologica: Potenta
garantata
Quercetina extr. stand. 98% - din (Sophora flavescens)
4. Quercetina farmacocinetica
si biodisponibilitatea la Quercetina
5. Quercetina un bioflavonoid
cu proprietati antioxidante
6. Teoria radicalilor liberi
in procesul de imbatrinire
Densitatea de neutralizare a radicalilor
liberi
Capacitate scazuta de neutralizare a radicalilor liberi
Suficienti antioxidanti de recomandat: Acid alfa
lipoic, Ceai Verde, Vitamina C, Glutation, Vitamin E, Carotenoizi,
Coenzima Q10 sau enzime antioxidante ca superoxid dismutaza
(SOD) care detoxifica radicalul superoxid, peroxidul de hidrogen (H2O2)
si Glutation peroxidaza (GPx) care detoxifica peroxizii celulari
Capacitate suficienta de neutralizare a radicalilor liberi
Quercetina cu capacitate de absorbtie a radicalului liber a oxigenului - ORAC,
comparatia valorilor fata de Vitamina C
Antioxidantii neutralizeaza radicali liberi
Formarea de radicali liberi
7. Quercetina un antioxidant
puternic inhiba prooxidante ca xantin oxidaza si activitatea xantin dehidrogenaza
8. Quercetina supliment nutritional
cu actiune antioxidanta la estrogeni si fitoestrogeni
9. Quercetina si Rutina cu actiune de chelare si antioxidanta
in peroxidarea lipidica
10. Quercetina agent chelator cu protectie antioxidanta
la membrana eritrocitelor si relatia de chelare a fierului
11. Importanta terapeutica de chelarea fierului : Toxicitatea de citokine
la precursori de oligodendrocite este mediata de fier in patogeneza neurodegenerativa
a bolilor Alzheimer,
Parkinson
si Scleroza Multipla
Chelare din lb. gr. chele care inseamna cleste adica atrage metalele
grele prin polarizare, le elimina prin rinichi
12. Quercetina agent chelator stabilizeza factorul indus
de hipoxie (HIF-1alfa) si inhiba proliferarea celulara, predominanta prin reducerea
concentratiei intracelulare de fier la chelarea fierului
13. Quercetina si catechinele
EGCG sint agenti chelatori cu actiune de chelare fierului
14. Quercetina si metabolitii epicatechin
ca EGCG participa ca antioxidanti in plasma sanguina
15. Quercetina
si Vitamina C cu efect protector de stresul oxidativ indus in neuro
degenerare
16. Quercetina si Ceai Verde extr. stand.
EGCG reduce nivelul plasmatic de lipide
17. Quercitina
si
metaboliti de catechine - EGCG reduce adeziunea de monocite in celulele
endoteliale
din aorta
18. Quercitina
si
metaboliti de epicatechine - EGCG in cresterea activitatii
enzimatice MCF7 la celulele de cancer mamar
19. Quercitina
si Acid Elagic cu sinergie in influenta de apoptoza a celulelor
de leucemie
20. Quercitina si Acid
Elagic interactioneaza sinergic cu Resveratrol, cu efect in apoptoza
celulelor de leucemie
33. Quercetina induce
cel mai puternic apoptoza la Rous sarcoma
34. Quercetina cu proprietati farmacologice
in tratamentul de inflamatie intestinala, a reducerii gazelor intestinale
(balonarilor)
35. Quercitina
si trans Resveratrol implicati in protectia bolilor coronariene, blocheaza
agregarea plachetara si sinteza
de eicosanoide
36. Quercetina cu efect la
hiperlipidemie si ateroscleroza
37. Quercetina cu efect de
vasodilatatie
Quercetina cu efect de vasodilatatie
38. Quercetina inhiba expresia
ICAM-1
in celulele endoteliale
39. Quercetina un potent inhibitor de
Acid arahidonic: Lipoxigenaza
Quercetina un potent inhibitor de Acid arahidonic: Lipoxigenaza
40. Quercetina cu efect favorabil in
modularea cascadei inflamatiei de ecosanoide, cicloxigenazaCOX si lipoxigenaza
este un adjunct in terapia de cancer
41. Quercetina un flavonoid
anti inflamator si antialergic
42. Quercetina cu potential antiinflamator
si antimicrobial la tratamentul de trypanomiasis-boala somnului (African
sleeping sickness)
43. Quercetina un antialergic
potent inhiba antigeni care induce histamina la alergie
44. Quercetina un antialergic
inhiba antigeni care induce histamina la alergie
45. Quercetina bioflavonoid
un agent
protector renal cu efect in ischemia renala
46. Quercetina bioflavonoid cu
efect in functia renala dupa transplant, studiu randomizat dublu orb placebo
controlat
47. Quercetina un produs
sigur in aplicatia clinica: Reviu
48. Quercetina in sinergie cu Resveratrol
creste biodisponibilitatea, prin inhibarea procesului de sulfatare
(Sulfation)
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1. Cragin, RB, The
use of bioflavonoids in the prevention and treatment
of athletic injuries, Medical Times 90 (1962): 529-532.
2. Shoskes DA, Zeitlin SI, Shahed A, Rajfer
J. Quercetin
in men with category III chronic prostatitis: a preliminary prospective, double-blind,
placebo-controlled trial. Institute for Male Urology, Encino, California,
USA. Urology. 1999 Dec;54(6):960-3.
3. Havsteen, B,. “Flavonoids,
a class of natural products of high pharmacological
potency.” Biochemical Pharmacology 1983;32(7):1141-48.
- Formica JV,
Regelson W. Review
of the biology of Quercetin and related bioflavonoids. Department of
Microbiology and Immunology, School of Medicine, Virginia Commonwealth University,
Richmond 23298-0678, USA. Food Chem Toxicol. 1995 Dec;33(12):1061-80. 4. Graefe EU, Wittig J, Mueller S, Riethling
AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. Pharmacokinetics
and bioavailability of quercetin glycosides in humans. Zentralinstitut
Arzneimittelforschung GmbH, Sinzig, Germany. J Clin Pharmacol. 2001 May;41(5):492-9.
5. Morand C, Crespy V, Manach C, Besson
C, Demigne C, Remesy C. Plasma
metabolites
of quercetin and their antioxidant properties. Laboratoire des Maladies Metaboliques
et des Micronutriments, Institut National de la Recherche Agronomique de Clermont-Ferrand/Theix,
63122 Saint-Genes-Champanelle,
France.
- Hollman PC, van Trijp JM,
Mengelers MJ, de Vries JH, Katan MB. Bioavailability
of the dietary antioxidant flavonol quercetin in man. DLO State Institute
for Quality Control of Agricultural Products (RIKLIT-DLO), Wageningen,
The Netherlands.
p.c.h.hollman@rikilt.dlo.nl Cancer Lett. 1997 Mar 19;114(1-2):139-40.
6. Beckman, K. & Ames, B. (1998) "The
free radical theory of aging matures" Physiol Rev 78: 548-81.
7. Bindoli A, Valente M, Cavallini L. Inhibitory
action of quercetin on xanthine
oxidase and xanthine dehydrogenase activity. Pharmacol Res Commun. 1985 Sep;17(9):831-9.
8. Wiseman H, O'Reilly J. Influence
of the dietary flavonoid quercetin on the cardioprotective antioxidant action
of oestrogen and phytoestrogens. Biochem Soc Trans. 1997 Feb;25(1):108S.
9. Afanas'ev IB, Dorozhko AI, Brodskii
AV, Kostyuk VA, Potapovitch AI. Chelating
and free radical scavenging mechanisms of inhibitory action of rutin and
quercetin in lipid peroxidation. All-Union Vitamin Research Institute,
Moscow, U.S.S.R. Biochem Pharmacol. 1989 Jun 1;38(11):1763-9.
10. Ferrali M, Signorini C, Caciotti B, Sugherini L, Ciccoli L, Giachetti
D, Comporti M. Protection against oxidative damage of erythrocyte membrane
by
the flavonoid
quercetin and its relation to iron chelating activity. Institute of General
Pathology, University of Siena, Italy. FEBS Lett. 1997 Oct 20;416(2):123-9.
11. Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N,
Connor JR. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
Department
of Neurosurgery, Pennsylvania State University, College of Medicine Hershey,
PA 17033, USA. Glia. 2005 Nov 15;52(3):199-208.
12. Triantafyllou A, Liakos P,
Tsakalof A, Chachami G, Paraskeva E, Molyvdas PA, Georgatsou E, Simos G, Bonanou
S. The flavonoid quercetin induces hypoxia-inducible
factor-1alpha (HIF-1alpha) and inhibits cell proliferation by depleting intracellular
iron. Laboratory of Biochemistry, Department of Medicine, School of Health
Sciences, University of Thessaly, Larissa, Greece. Free Radic Res. 2007 Mar;41(3):342-56.
13.
Morel, I.; Lescoat, G.; Cogrel, P.; Sergent. O.; Pasdeloup, N.; Brissot,
P.; Cillard, P.; Cillard, J. Antioxidant
and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin
on iron-loaded rat hepatocyte cultures. Laboratoire de Biologie Cellulaire
et Vegetale, UFR des Sciences Pharmaceutiques, Rennes, France. Biochem Pharmacol.
1993 Jan 7;45(1):13-9
14. Terao J. Dietary flavonoids as
antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin
participate
in antioxidative defense in blood
plasma. J Med Invest. 1999 Aug;46(3-4):159-68.
15. Heo HJ, Lee CY. Protective
effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration.
Department of Food Science and Technology, Cornell University, Geneva, NY
14456, USA.
J Agric Food Chem. 2004 Dec 15;52(25):7514-7.
16. Bok SH, Park SY, Park YB, Lee
MK, Jeon SM, Jeong TS, Choi MS. Quercetin
dihydrate and gallate supplements lower plasma and hepatic lipids and change
activities of hepatic antioxidant enzymes in high cholesterol-fed rats. Korea
Research Institute of Bioscience and Biotechnology, P.O. Box 115, Yusong,
Taejon, 305-606, Korea. Int J Vitam Nutr Res. 2002 May;72(3):161-9.
17. Koga T, Meydani M. Effect
of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion
to human aortic endothelial cells. Vascular Biology Laboratory, Jean Mayer
US Department of Agriculture Human Nutrition Research Center on Aging at
Tufts
University,
Boston. Am J Clin Nutr. 2001 May;73(5):941-8.
18. Rodgers EH, Grant MH. The
effect of the flavonoids, quercetin, myricetin and epicatechin on the growth
and enzyme activities of MCF7 human breast cancer
cells. Bioengineering Unit, University of Strathclyde, Wolfson Centre, Glasgow,
Scotland, UK. Chem Biol Interact. 1998 Nov 27;116(3):213-28.
19. Mertens-Talcott
SU, Talcott ST, Percival SS. Low
concentrations of quercetin and ellagic acid synergistically influence proliferation,
cytotoxicity and apoptosis in MOLT-4 human leukemia cells. Food Science
and Human Nutrition Department, University of Florida, Gainesville, FL 32611,
USA. J Nutr. 2003 Aug;133(8):2669-74.
20. S. Mertens-Talcott, S. Percival Ellagic
acid and quercetin interact synergistically with resveratrol in the induction
of apoptosis and cause transient cell cycle arrest in human leukemia cells.
Department of Food Science and Human Nutrition, Institute of Food and Agricultural
Sciences,
University of Florida, P.O. Box 110370, Gainesville, FL 32611-0370, USA Cancer
Letters, Volume 218, Issue 2, Pages 141-151
21. Csokay B, Prajda N, Weber
G, Olah E. Molecular
mechanisms in the antiproliferative
action of quercetin. National Institute of Oncology, Dept. Molecular Biology,
Budapest, Hungary. Life Sci. 1997;60(24):2157-63.
22. Akagi K, Hirose M, Hoshiya
T, Mizoguchi Y, Ito N, Shirai T. Modulating
effects of ellagic acid, vanillin and quercetin in a rat medium term
multi-organ carcinogenesis
model. First Department of Pathology, Nagoya City University, Medical School,
Japan. Cancer Lett. 1995 Jul 20;94(1):113-21.
23. Igura K, Ohta T, Kuroda Y,
Kaji K. Resveratrol
and quercetin inhibit angiogenesis in vitro. Laboratory of Cell and
Molecular Biology of Aging, Graduate School of Nutritional and Environmental
Sciences, University of Shizuoka, Yada, 422-8526, Shizuoka, Japan.
Cancer Lett. 2001 Sep 28;171(1):11-6.
24. Blardi P, De Lalla A, Volpi L,
Di Perri T. Stimulation
of endogenous adenosine release by oral administration of quercetin and resveratrol
in man. Department of Internal Medicine, University of Siena, Italy. Blardi@unisi.it
Drugs Exp Clin Res. 1999;25(2-3):105-10.
25. ElAttar TM, Virji AS. Modulating
effect of resveratrol and quercetin on oral cancer cell growth and
proliferation. Hormone Research Laboratory, University of Missouri-Kansas
City, School of Dentistry, 64108-2784, USA. virjia@umkc.edu Anticancer Drugs.
1999
Feb;10(2):187-93.
26. Castillo MH, Perkins E, Campbell
JH, Doerr R, Hassett JM, Kandaswami C, Middleton E Jr. The
effects of the bioflavonoid quercetin on squamous cell carcinoma of head
and neck origin. Department of Otolaryngology, State University of New York,
Sisters
of Charity Hospital, Buffalo, New York. Am J Surg. 1989 Oct;158(4):351-5.
27. Caltagirone S, Rossi C, Poggi
A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M. Flavonoids
apigenin and quercetin inhibit melanoma growth and metastatic potential.
Department of Oncology and Neurosciences, G. D'Annunzio University, Chieti,
Italy. caltagir@cmns.mnegri.it
Int J Cancer. 2000 Aug 15;87(4):595-600.
28. Xing N, Chen Y, Mitchell SH, Young
CY. Quercetin
inhibits the expression and function of the androgen receptor in LNCaP prostate
cancer cells. Department of Urology and Biochemistry and Molecular Biology,
Mayo Graduate School, Mayo Foundation, Rochester, MN 55905, USA. Carcinogenesis.
2001 Mar;22(3):409-14.
29. Vijayababu MR, Arunkumar A, Kanagaraj
P, Arunakaran J. Effects
of quercetin on insulin-like growth factors (IGFs) and their binding protein-3
(IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells.
Department of Endocrinology, Dr, ALM Postgraduate Institute of BasicMedical
Sciences,
University of Madras, Taramani campus, Chennai-600 113, INDIA. j_arunakaran@hotmail.com.
J Carcinog. 2006 Apr 6;5:10.
30. Nair HK, Rao KV, Aalinkeel R,
Mahajan S, Chawda R, Schwartz SA. Inhibition
of prostate cancer cell colony formation by the flavonoid quercetin correlates
with modulation of specific regulatory genes. Division of Allergy, Immunology
and Rheumatology, Department of Medicine, State University of New York at
Buffalo and Kaleida Health, Buffalo, New York 14203, USA. Clin Diagn Lab
Immunol. 2004
Jan;11(1):63-9.
31. Mouat MF, Kolli K, Orlando R, Hargrove
JL, Grider A. The
effects of quercetin on SW480 human colon carcinoma cells: a proteomic study.
Department of Foods and Nutrition, University of Georgia, Athens, Georgia
30602, USA. mmouat@fcs.uga.edu Nutr J. 2005 Mar 4;4:11.
32. Richter M, Ebermann R, Marian B. Quercetin-induced
apoptosis in colorectal tumor cells: possible role of EGF receptor
signaling. Institute for Tumor Biology-Cancer Research, University of Vienna,
Austria. Nutr Cancer. 1999;34(1):88-99.
33. Graziani, Y., Erikson, E., Erikson,
R.L.: The
effect of quercetin on the phosphorylation activity of the Rous sarcoma virus
transforming gene product in vitro and in vivo. Eur. J. Biochem. 135: 583-589,
1983.
34. Kim H, Kong H, Choi B, Yang Y,
Kim Y, Lim MJ, Neckers L, Jung Y. Metabolic
and pharmacological properties of rutin, a dietary quercetin glycoside, for
treatment of inflammatory bowel disease. Laboratory of Biomedicinal Chemistry,
College of Pharmacy, Pusan National University, Jangjeon-Dong, Keumjung-Gu,
Pusan 609-735, Republic of Korea.
35. Pace-Asciak CR, Hahn S, Diamandis
EP, Soleas G, Goldberg DM. The
red wine phenolics trans-resveratrol and quercetin block human platelet aggregation
and eicosanoid synthesis: implications for protection against coronary heart
disease. Department of Pharmacology, University of Toronto, Canada. Clin
Chim Acta. 1995 Mar 31;235(2):207-19.
36. Juzwiak S, Wojcicki J, Mokrzycki
K, Marchlewicz M, Bialecka M, Wenda-Rozewicka L, Gawronska-Szklarz B, Drozdzik
M. Effect
of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits.
Department of Pharmacology, Pomeranian Medical University, Powstancow Wlkp.
72, PL 70-111
Szczecin, Poland. Pharmacol Rep. 2005 Sep-Oct;57(5):604-9.
37. Perez-Vizcaino F, Ibarra M, Cogolludo
AL, Duarte J, Zaragoza-Arnaez F, Moreno L, Lopez-Lopez G, Tamargo J. Endothelium-independent
vasodilator effects of the flavonoid quercetin and its methylated metabolites
in rat conductance and resistance arteries. Department of Pharmacology,
Institute of Pharmacology and Toxicology, School of Medicine, University
Complutense of Madrid, 28040 Madrid, Spain. fperez@eucmail.ucm.es J Pharmacol
Exp Ther.
2002 Jul;302(1):66-72.
38. Kobuchi H, Roy S, Sen CK, Nguyen
HG, Packer L. Quercetin
inhibits inducible ICAM-1 expression in human endothelial cells through the
JNK pathway. Environmental Energies Technologies Division, Lawrence Berkeley
National Laboratory, Berkeley, California 94720, USA. Am J Physiol. 1999
Sep;277(3 Pt 1):C403-11.
39. Yoshimoto T, Furukawa M, Yamamoto
S, Horie T, Watanabe-Kohno S. Flavonoids:
potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun.
1983 Oct 31;116(2):612-8.
40. Wallace JM. Nutritional
and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases,
and lipoxygenases--as an adjunct in cancer therapy. Nutritional Solutions,
Inc., 2935 North, 1000 East, North Logan, UT 84341, USA. BTnutrition@aol.com
Integr Cancer Ther. 2002 Mar;1(1):7-37; discussion 37.
41. Gabor M. Anti-inflammatory
and anti-allergic properties of flavonoids. Prog Clin Biol Res. 1986;213:471-80.
42. Mamani-Matsuda M, Rambert J, Malvy
D, Lejoly-Boisseau H, Daulouede S, Thiolat D, Coves S, Courtois P, Vincendeau
P, Mossalayi MD. Quercetin
induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory
response of human macrophages. Laboratoires d'Immunologie et de Parasitologie,
E.A. 3677, Bases Therapeutiques Anti-Infectieuses et Anti-Inflammatoires,
Universite Bordeaux II, France. maria.mamani@u-bordeaux2.fr Antimicrob Agents
Chemother.
2004 Mar;48(3):924-9.
43. Pearce, F.L., Befus, A.D., Bienenstock,
J., “Mucosal
mast cells III. Effect of quercetin and other flavonoids on antigen-induced
histamine secretion
from rat intestinal mast cells.” J. J Allergy Clin Immunol. 1984 Jun;73(6):819-23.
44. Middleton, E. Drzewiecki, G., Krishnarao,
D., “Quercetin:
an inhibitor of antigen-induced human basophil histamine release.” J.
of Immunology
1981;127(2):546-50.
45. Shoskes DA. Effect
of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class
of renoprotective agents. Department of Surgery, Harbor-UCLA Medical Center,
UCLA School of Medicine, Torrance, California 90509, USA. dshoskes@ucla.edu
Transplantation.
1998 Jul 27;66(2):147-52.
46. Shoskes D, Lapierre C, Cruz-Correa
M, Muruve N, Rosario R, Fromkin B, Braun M, Copley J. Beneficial
effects of the bioflavonoids curcumin and quercetin on early function in
cadaveric renal transplantation: a randomized placebo controlled trial. Department
of Kidney Transplantation, Cleveland Clinic Florida, Weston, FL, USA. dshoskes@mac.com
Transplantation. 2005 Dec15;80(11):1556-9
47. Okamoto T. Safety
of quercetin for clinical application (Review). Research Laboratories, Nippon
Chemiphar Co., Ltd., 1-22 Hikokawato, Misato, Saitama 341-0005, Japan.
Int J Mol Med. 2005 Aug;16(2):275-8.
48. De Santi C, Pietrabissa A, Spisni
R, Mosca F, Pacifici GM. Sulphation
of resveratrol, a natural product present in grapes and wine, in the human
liver
and duodenum. Department of Neurosciences, Medical School, Pisa, Italy. Xenobiotica.
2000 Jun;30(6):609-17.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.